american diabetes association pancreatitis glp-1 receptor agonist history Frontiers Why Does GLP-1 Cause Pancreatitis?

To the best of our knowledge, this meta-analysis is the first to evaluate the effects and safety of SGLT2i and GLP-1RAs as first-line therapy for T2DM with low cardiovascular risk

Doctoring our diet II: nutrition education for physicians is overdue

The SELECT trial demonstrated a 20% reduction in major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in people with obesity and established cardiovascular disease

Numerous studies have found that GLP-1 agonists can be effective for weight loss, blood sugar management, and heart health, especially when combined with diet and lifestyle changes